Cesar J, García-Avello A, Navarro J, Herraez M (2004). “Aging and oral anticoagulant therapy using acenocoumarol”. Blood Coagul Fibrinolysis. 15 (8): 673–6. doi:10.1097/00001721-200412000-00007. PMID15613922.
Lengyel M; SPORTIF-III Altanulmány Vizsgálói (2004). “Warfarin or acenocoumarol is better in the anticoagulant treatment of chronic atrial fibrillation?”. Orv Hetil. 145 (52): 2619–21. PMID15724697.
Ufer M (2005). “Comparative pharmacokinetics of vitamin Kd antagonists: warfarin, phenprocoumon and acenocoumarol”. Clin Pharmacokinet. 44 (12): 1227–46. doi:10.2165/00003088-200544120-00003. PMID16372822.
Montes R, Ruiz de Gaona E, Martínez-González M, Alberca I, Hermida J (2006). “The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients”. Br J Haematol. 133 (2): 183–7. doi:10.1111/j.1365-2141.2006.06007.x. PMID16611310.
